Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Native Tissue Repair (Colporrhaphy)
Treatment for Genital prolapse
Effectiveness
70%
Safety Score
65%
Clinical Trials
1
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate anatomical correction; symptom resolution 4-8 weeks post-op
Treatment Duration
One-time surgery, recovery 6-8 weeks
Evidence Quality
MODERATENumber Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
7(Treat 7 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$500
Total Annual:$13,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$50,000/QALY
QALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$17,333.33
Cost per Remission
$20,000
Comparison vs Vaginal Pessary
Cost Difference
+$12,300/year
More expensive
QALY Difference
+0.30 QALYs
Better outcomes
Dominance
No dominance
Native Tissue Repair (Colporrhaphy) Outcomes
for Genital prolapse
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+75%
Remission Rate
+65%
Common Side Effects
Post-operative pain
+40%
Infection
+7%
Bleeding/Hematoma
+7%
Dyspareunia (painful intercourse)
+15%
Urinary symptoms (e.g., urgency, stress incontinence)
+15%
Recurrence of prolapse
+25%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov